Transforming targeted cancer therapy with PROTACs: A forward-looking perspective

W Farnaby, M Koegl, DB McConnell, A Ciulli - Current opinion in …, 2021 - Elsevier
Small-molecule targeted protein degraders have in recent years made a great impact on the
strategies of many industry and academic cancer research endeavours. We seek here to …
被引用次数：42 相关文章

Transforming targeted cancer therapy with PROTACs: A forward-looking perspective.

W Farnaby, M Koegl, DB McConnell… - Current Opinion in …, 2021 - europepmc.org
Small-molecule targeted protein degraders have in recent years made a great impact on the
strategies of many industry and academic cancer research endeavours. We seek here to …

Transforming targeted cancer therapy with PROTACs: A forward-looking perspective

W Farnaby, M Koegl… - Current Opinion in …, 2021 - discovery.dundee.ac.uk
Small-molecule targeted protein degraders have in recent years made a great impact on the
strategies of many industry and academic cancer research endeavours. We seek here to …

[引用][C] Transforming targeted cancer therapy with PROTACs: A forward-looking perspective

W Farnaby, M Koegl, DB McConnell… - Current Opinion in …, 2021 - cir.nii.ac.jp
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Transforming targeted cancer therapy with PROTACs: A forward-looking perspective

W Farnaby, M Koegl… - Current opinion in …, 2021 - pubmed.ncbi.nlm.nih.gov
Small-molecule targeted protein degraders have in recent years made a great impact on the
strategies of many industry and academic cancer research endeavours. We seek here to …
[PDF] dundee.ac.uk

[PDF][PDF] Transforming targeted cancer therapy with PROTACs

W Farnaby, M Koegl, DB McConnell, A Ciulli - 2021 - discovery.dundee.ac.uk
Recent years have brought a wave of pre-clinical and clinical studies utilising bifunctional
degrader molecules, known as proteolysis targeting chimeras (PROTACs). PROTAC …